Research Grade Ponezumab ( 泊奈组单抗 )
- 发布日期： 2020-10-28
- 更新日期： 2025-10-24
产品详请
| 产地 |
中国
|
| 品牌 |
Chemstan
|
| 货号 |
CSD00252
|
| 保存条件 |
store at -80℃
|
| 用途 |
仅用于科研用途
|
| 应用范围 |
|
| 抗原来源 |
CHO cells
|
| CAS编号 |
1178862-65-1
|
| 保质期 |
一年
|
| 抗体名 |
Ponezumab ( 泊奈组单抗 )
|
| 是否单克隆 |
|
| 克隆性 |
|
| 靶点 |
APP Abeta40[Homo sapiens]
|
| 适应物种 |
|
| 形态 |
|
| 宿主 |
|
| 标记物 |
|
| 包装规格 |
1mg/ml
|
| 纯度 |
%
|
| 亚型 |
|
| 标识物 |
|
| 浓度 |
95%
|
| 免疫原 |
|
| 是否进口 |
否
|
Ponezumab is under investigation in clinical trial NCT00607308 (A Phase I, Single Dose Study Of PF-04360365 In Japanese Patients With Mild To Moderate Alzheimer's Disease).
货号（Catalog No.）
CSD00252
通用名INN
Ponezumab
纯度(Purity)
>95%
浓度( Concentration)
1mg/ml
Formulation
PBS buffer pH7.5
Source
CHO cells
内毒素(Endotoxin level)
Please contact with the lab for this information.
生物活性
产品描述(Description)
Ponezumab is under investigation in clinical trial NCT00607308 (A Phase I, Single Dose Study Of PF-04360365 In Japanese Patients With Mild To Moderate Alzheimer's Disease).
别名(Alternative names)
PF-04360365,RN-1219,clone 9TL
靶点;物种(Specificity target name;species)
APP Abeta40[Homo sapiens]
种类(Species)
Humanized
受体鉴定(Receptor identification)
IgG2-kappa
化学信息
CAS
1178862-65-1
存储条件(Storage)
store at -80°C
Note
For research use only. Not suitable for clinical or therapeutic use.
